| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/24/2007 | US7208493 Vasculostatic agents and methods of use thereof |
| 04/24/2007 | US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 04/19/2007 | WO2007044813A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα |
| 04/19/2007 | WO2007044779A1 Kinase inhibitors |
| 04/19/2007 | WO2007044698A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα |
| 04/19/2007 | WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/19/2007 | WO2007043835A1 Fab i inhibitor and process for preparing same |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042883A1 Inhibitors of the hiv integrase enzyme |
| 04/19/2007 | WO2007042321A2 Kinase inhibitors |
| 04/19/2007 | WO2007042240A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 04/19/2007 | WO2007041790A1 Salts of proton pump inhibitors and process for preparing same |
| 04/19/2007 | WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof |
| 04/19/2007 | WO2006101217A3 Luminous compound containing lanthanide ion |
| 04/19/2007 | WO2006073939A3 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
| 04/19/2007 | US20070088163 Modulators of calcitonin and amylin activity |
| 04/19/2007 | US20070088159 Hydroxyalkyl cyclic diamine compounds |
| 04/19/2007 | US20070088054 Biphenyl derivatives |
| 04/19/2007 | US20070088047 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088046 cerebral oxygenators and vasoregulators; antidepressant, cognition activator; sleep disorders; enantiomer mixture separated by HPLC; classical antidepressants resistance |
| 04/19/2007 | US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/19/2007 | US20070088037 Cancer and fibrotic diseases |
| 04/19/2007 | US20070088029 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/19/2007 | US20070088025 Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid cb1 receptor agonists |
| 04/19/2007 | US20070088018 Cb1 antagonist compounds |
| 04/19/2007 | DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases |
| 04/19/2007 | CA2625962A1 Fab i inhibitor and process for preparing same |
| 04/19/2007 | CA2625763A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 04/19/2007 | CA2625196A1 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| 04/19/2007 | CA2624965A1 Pyridopyrimidinone inhibitors of pi3k.alpha. |
| 04/19/2007 | CA2624610A1 Kinase inhibitors |
| 04/19/2007 | CA2623770A1 Pyridopyrimidinone inhibitors of pi3k.alpha. |
| 04/19/2007 | CA2623506A1 Inhibitors of the hiv integrase enzyme |
| 04/19/2007 | CA2623500A1 Kinase inhibitors |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2622755A1 Mek inhibitors and methods of their use |
| 04/18/2007 | EP1775296A1 Alcohol oxidation catalyst and method of synthesizing the same |
| 04/18/2007 | EP1773847A2 Antibacterial agents |
| 04/18/2007 | EP1773835A2 Pyrido-pyrido-pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 04/18/2007 | EP1773834A2 2, 8-disubstituted naphthyridine derivatives |
| 04/18/2007 | EP1773833A2 Pyrrolo(oxo)quinolines as 5ht ligands |
| 04/18/2007 | EP1773832A2 Dipeptidyl peptidase inhibitors |
| 04/18/2007 | EP1773831A1 Antibacterial agents |
| 04/18/2007 | EP1773830A1 Fused pyrimidones useful in the treatment and the prevention of cancer |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773807A2 Kinase inhibitors |
| 04/18/2007 | EP1773771A2 Compounds and methods for treatment of thrombosis |
| 04/18/2007 | EP1773345A2 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/18/2007 | EP1773343A1 Antibacterial agents |
| 04/18/2007 | EP1583531B1 Heteroaryl-substituted pyrrolo[2, 3- b]pyridine derivatives as crf receptor antagonists |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1537109B1 Novel benzonaphthyridines |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1451161B1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | CN1950374A Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950371A Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 04/18/2007 | CN1950370A Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
| 04/18/2007 | CN1950358A Novel gamma secretase inhibitors |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 04/18/2007 | CN1950083A Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors |
| 04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
| 04/18/2007 | CN1948311A 2-iodine substituted phenyl-6-trifluoro methyl imidazole [1,2-a]-pyridine-3-acetamide compounds and its preparation method |
| 04/18/2007 | CN1948310A 3 position substituted mesoazalene compounds and high efficiency synthesis method |
| 04/18/2007 | CN1948309A Organic eurepium compound based on functional o-phenan throline ligand and its electroluminous device |
| 04/18/2007 | CN1948308A Intermediate compound for synthesizing lamel larin H and its derivatives and synthesizing method |
| 04/18/2007 | CN1948298A Dopamine D3 acceptor portion agonist and its application |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310917C Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/18/2007 | CN1310916C Hetero-bicyclic compounds |
| 04/18/2007 | CN1310915C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205407 3-Substituted oxindole β3 agonists |
| 04/17/2007 | US7205405 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one |
| 04/17/2007 | US7205401 Separation of such enantiomers with non-chromatographic resin bed separations of three separation stages or less; efficiency; chiral purity |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205305 Inhibitors of p38 |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205299 Indole derivatives having an apoptosis-inducing effect |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2202775C Method for treating anxiety |
| 04/17/2007 | CA2141589C Antiretroviral enantiomeric nucleotide analogs |
| 04/17/2007 | CA2106882C Azaquinoxalines, processes for their preparation and their use |
| 04/12/2007 | WO2007041616A1 Piperazine amidines as antiviral agents |
| 04/12/2007 | WO2007041379A1 Met kinase inhibitors |
| 04/12/2007 | WO2007041362A1 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones |
| 04/12/2007 | WO2007041052A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 04/12/2007 | WO2007041023A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |